1. Home
  2. AUTL vs MAX Comparison

AUTL vs MAX Comparison

Compare AUTL & MAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Autolus Therapeutics plc

AUTL

Autolus Therapeutics plc

SELL

Current Price

$1.14

Market Cap

335.4M

Sector

Health Care

ML Signal

SELL

Logo MediaAlpha Inc.

MAX

MediaAlpha Inc.

SELL

Current Price

$14.82

Market Cap

657.4M

Sector

Industrials

ML Signal

SELL

Company Overview

Basic Information
Metric
AUTL
MAX
Founded
2014
2014
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Industrial Machinery/Components
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
335.4M
657.4M
IPO Year
2025
2020

Fundamental Metrics

Financial Performance
Metric
AUTL
MAX
Price
$1.14
$14.82
Analyst Decision
Strong Buy
Buy
Analyst Count
9
8
Target Price
$8.36
★ $15.86
AVG Volume (30 Days)
★ 2.5M
1.1M
Earning Date
11-10-2026
10-28-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 25.81
EPS
N/A
★ 1.32
Revenue
$10,120,000.00
★ $1,113,600,000.00
Revenue This Year
$101.75
$22.43
Revenue Next Year
$29.27
$10.60
P/E Ratio
★ N/A
$11.23
Revenue Growth
★ 496.00
28.78
52 Week Low
$1.07
$7.09
52 Week High
$2.58
$15.99

Technical Indicators

Market Signals
Indicator
AUTL
MAX
Relative Strength Index (RSI) 23.84 66.12
Support Level N/A $13.28
Resistance Level $1.71 $15.99
Average True Range (ATR) 0.12 0.89
MACD -0.02 0.01
Stochastic Oscillator 12.93 71.79

Price Performance

Historical Comparison
AUTL
MAX

About AUTL Autolus Therapeutics plc

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8. Company's T cell programming technologies tailors therapies to address the specific disease targeting and introduce new programming modules into a patient's T cells to give those T cells improved properties to recognize target cells and overcome fundamental disease defense mechanisms.

About MAX MediaAlpha Inc.

MediaAlpha Inc provides a platform that enables insurance carriers and distributors to target and acquire customers. The company's technology platform brings insurance carriers and consumers together through a real-time, transparent, and results-driven ecosystem. It serves as a customer acquisition channel in property and casualty insurance, health insurance, and life insurance. The company operates in the United States and generates revenue by earning a fee for each consumer referral sold on its platform.

Share on Social Networks: